Učitavanje...
Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit.
A therapeutic trial with verapamil, a calcium-antagonist drug, was performed in 12 patients admitted to our coronary care unit because of frequent daily attacks of angina at rest attributed to coronary vasospasm. After a 48-hour run-in period, oral verapamil 480 mg/day and placebo were administered...
Spremljeno u:
| Izdano u: | Br Heart J |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
1979
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC486844/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/371644/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.41.2.167 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|